ZNTL
Zentalis Pharmaceuticals Llc
2.50$
-3.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -173,221.4% | – | – | – | – | – | -253.4% | – | |
| 364.3% | – | – | – | – | – | 1.9% | – | |
| 2,200.0% | – | – | – | – | – | 99.8% | – | |
| 2,200.0% | – | – | – | – | – | – | – | |
| -8,414.3% | – | – | – | – | – | -24.5% | – | |
| 1,621.4% | – | – | – | – | – | 0.3% | – | |
| -1,621.4% | – | – | – | – | – | 261.9% | – | |
| 67,657.1% | – | – | – | – | – | 0.0% | – | |
| 67,657.1% | – | – | – | – | – | 0.2% | – | |
| -107,185.7% | – | – | – | – | – | 8.6% | – | |
| -174,842.9% | – | – | – | – | – | -253.7% | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.